Home2VSA • FRA
add
Verastem Inc
Nakaraang pagsara
€3.54
Sakop ng araw
€3.94 - €4.34
Sakop ng taon
€1.90 - €7.35
Market cap
263.76M USD
Average na Volume
72.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 44.17M | 57.43% |
Net na kita | -52.10M | -53.86% |
Net profit margin | — | — |
Kita sa bawat share | -0.79 | 19.39% |
EBITDA | -44.16M | -57.43% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 117.57M | 6.76% |
Kabuuang asset | 131.70M | 6.60% |
Kabuuang sagutin | 164.13M | 112.28% |
Kabuuang equity | -32.43M | — |
Natitirang share | 54.95M | — |
Presyo para makapag-book | -5.62 | — |
Return on assets | -94.70% | — |
Return on capital | -382.64% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Net na kita | -52.10M | -53.86% |
Cash mula sa mga operasyon | -38.68M | -36.63% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 67.43M | 7,870.09% |
Net change in cash | 28.75M | 717.25% |
Malayang cash flow | -24.28M | -29.15% |
Tungkol
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Itinatag
2010
Headquarters
Website
Mga Empleyado
78